Share Name Share Symbol Market Type Share ISIN Share Description
Redx Pharma Plc LSE:REDX London Ordinary Share GB00BSNB6S51 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 77.50 6,208 08:00:11
Bid Price Offer Price High Price Low Price Open Price
75.00 80.00 77.50 77.50 77.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.69 -9.17 -5.40 213
Last Trade Time Trade Type Trade Size Trade Price Currency
16:28:36 O 1,303 79.90 GBX

Redx Pharma (REDX) Latest News

More Redx Pharma News
Redx Pharma Investors    Redx Pharma Takeover Rumours

Redx Pharma (REDX) Discussions and Chat

Redx Pharma Forums and Chat

Date Time Title Posts
15/9/202110:45Redx Pharma PLC504
02/7/202008:39REDX Pharma Discussion Thread Moderated157

Add a New Thread

Redx Pharma (REDX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Redx Pharma trades in real-time

Redx Pharma (REDX) Top Chat Posts

Redx Pharma Daily Update: Redx Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker REDX. The last closing price for Redx Pharma was 77.50p.
Redx Pharma Plc has a 4 week average price of 74.50p and a 12 week average price of 56p.
The 1 year high share price is 128p while the 1 year low share price is currently 49.20p.
There are currently 275,282,205 shares in issue and the average daily traded volume is 207,951 shares. The market capitalisation of Redx Pharma Plc is £213,343,708.88.
macmoss: I’m being greedy, average buy price is 53p but I’ll stick with it.
wapper: Added to my KOD holding with some of REDX cash
knitcraft: Any update amrish? I think we would all appreciate your views on the future of Redx and it’s share price
wapper: Thanks Knitcraft. Good article. £1.35 price target
knitcraft: A very good appraisal of Redx in today’s Sunday Times Business Section. Finishes off with a “buy” recommendation. Worth a read..
knitcraft: Looks like RedX is coming good for investors. Anyone who can be bothered to look more deeply into what has been achieved in the last 12 months will realise what an opportunity presents itself. They are on the cusp of tremendous results to benefit cancer and fibrosis patients. There are only 8% of the shares available in the market. Any positive news from just one of their research projects will transform RedX.They are presenting to a conference in the US in 10 days. Look into the background of the team for any reassurance on what they bring to the company. Funding is in place for two years of funding at the end of which the share price could be many multiples of today's breakout figure of 75.
kennylogsin: Supercity - thanks for pointing out the 92% holding. I was running from the email alert issued by HL yesterday which opened with: Our Reference: 02648800 Dear Mr XXXXXXX RedX Pharma plc - Your holding of xx,xxx Shares Extended Cash Offer - Important information that requires your attention What is happening? Redmile Group recently bought approximately 39.5% of the RedX Pharma plc shares in issue at a price of 15.5p per share. Under UK company law the company has to offer to buy all remaining RedX shares at the same price. As a holder of RedX Pharma plc Shares in your Hargreaves Lansdown Stocks & Shares ISA you need to decide whether you wish to accept the Offer or not. At the time of writing RedX Pharma plc Shares are trading at 45p so you may get less cash by accepting this offer than you would trading your Shares in the market. The other part I stated was at the bottom of the communication: What happens if I do not accept the Offer? If Redmile is able to obtain acceptances for 90% of the Company's Shares then they can force all remaining Shareholders to sell their Shares at the offer price. Redmile has indicated that if it receives acceptances in excess of 90% it does not currently intend to exercise its rights to compulsorily acquire the remaining RedX Pharma plc Shares. If the Company receives acceptances in excess of 90% and does move to compulsorily acquire the remaining Shares, we will put forward your holding for acceptance of the Offer, as long as it remains open, in order to ensure that you receive proceeds in respect of your holding as soon as possible. If not you will receive the proceeds once the Compulsory Acquisition has been completed. Redmile has stated that it intends to maintain RedX Pharma plc’s listing on AIM. However, if AIM is no longer considered a suitable market for RedX shares, Redmile may seek to move to a different market or trading facility. Super - as I got this yesterday how is it 8 week old information? Was something issued somewhere else? Any advice welcome...
global nomad: received reminder notice from iweb today...apologies to hahmedk for misconstruing his previous posts...para 3 and 4 are key but still a little vague...questions is still about selling on market asap or gambling on the listing remaining active after aug 24th - those paragraphs seem to suggest it might. ---- originally published by iweb on 19th June Further to our previous correspondence, Redmile has received valid acceptances of the Offer in respect of approximately 91.76 percent of the existing issued share capital of REDX as of 30th April 2020. Consequently, as Redmile has received acceptances under the Offer in respect of, and/or otherwise acquired 90 percent or more of the REDX shares in issue, Redmile is required to notify shareholders of their rights pursuant to the provisions of sections 983-985 of the Companies Act 2006 (The Act) to require Redmile to acquire the remaining REDX shares on the same terms as the Offer. Please note, it is not Redmile's intention to exercise their right under Chapter 3 of Part 28 of the Act to acquire compulsorily the remaining Ordinary shares to which the Offer relates and in respect of which the Offer has not been accepted. Redmile intends to maintain the admission of REDX Shares to trading on AIM immediately after the Offer. Should REDX be deemed to be unsuitable for admission to trading on AIM following Completion for any reason Redmile intends to investigate whether a listing on an alternative exchange or establishing an alternative trading facility would provide material benefits to shareholders through the continued ability to trade their shares. Before making any decision please take into consideration all relevant factors of the event including the current share price and any possible tax implications. If you require any further information in making your decision please contact an appropriate professional advisor. Please be aware that should you choose to accept the Offer, we do not yet know when the cash proceeds will be paid. However, we will notify you once your entitlement has been credited to your account. Should you choose not to accept the Offer at this time, we will contact you again if the Offer is extended, the terms of the Offer change, or if we are notified that the Offer is closing. Please note that acceptance to this Offer will only be applied to the number of shares you hold at the time we process your instruction. Please note that should you elect to accept the Offer, your shares will be removed from your account after our Advice Date and will not be available for you to sell. Should you wish to find more information about the Offer, please visit www.redxpharma.com/ What Happens If I Don't Elect ? If you do not wish to accept the Offer at this stage then you should take no action.
thefartingcommie: Redx Pharma set to be bought by US investment group UK biotech firm Redx Pharma (AIM: REDX) has a new majority shareholder, investment group Redmile, after the USA-based company bought up nearly 40% of the company, bringing its total shareholding to over 45%. Under takeover rules, Redmile must now make a cash offer for any remaining shares at the same price, of 15.5p ($0.20), valuing the company at around £29,45 million. UK biotech firm Redx Pharma (AIM: REDX) has a new majority shareholder, investment group Redmile, after the USA-based company bought up nearly 40% of the company, bringing its total shareholding to over 45%. Under takeover rules, Redmile must now make a cash offer for any remaining shares at the same price, of 15.5p ($0.20). Redx said that it would recommend unanimously to shareholders that the offer be accepted. hTTps://www.thepharmaletter.com/article/redx-pharma-set-to-be-bought-by-us-investment-group
thefartingcommie: hTTps://www.sharesmagazine.co.uk/news/market/6828551/RECOMMENDED-MANDATORY-OFFER-FOR-REDX-PHARMA-PLC Under the Offer, which will be subject to the Acceptance Condition and further terms of which are set out in Appendix 1 of this Announcement and which will be set out in full in the Offer Document and Form of Acceptance, Redx Shareholders will receive: 15.5 pence in cash for each Redx Share held. · The Offer will extend to all issued Redx Shares which are not held by Redmile and any further Redx Shares which are unconditionally allotted or issued and fully paid before the Offer closes. · As a result of the Acquisition, Redmile will, in aggregate, hold 86,498,896 Redx Shares, representing approximately 45.5 per cent. of the existing issued share capital and voting rights of Redx. · The Offer Price represents a premium of approximately 210% per cent. to the Closing Price per Redx Share of 5 pence on 12 March 2020 (being the Last Practicable Date prior to the date of this Announcement).
Redx Pharma share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Redx Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211017 04:33:34